Source BioScience has signed a three-year agreement with Sectra to use its Image Exchange Portal, aiming to digitally route up to 60,000 NHS pathology cases to external specialist pathologists in the first year.
MolDX has proposed a draft Local Coverage Determination to establish Medicare coverage criteria for optical genome mapping in hematologic neoplasms, with public comment open through Oct. 11, 2026, according to Bionano Laboratories.
From clot formation to functional and antigen testing, fibrinogen measurement helps laboratories evaluate bleeding disorders, monitor critical illness, and support patient care.
Hamamatsu Photonics received FDA 510(k) clearance for its NanoZoomer S20MD and S540MD slide scanner systems, expanding digital pathology options for clinical labs to include compact benchtop and high-throughput workflows.
AI models analyzing routine H&E slides can identify genomic alterations and immune patterns in NSCLC, supporting biomarker discovery and patient stratification, according to studies to be presented by Lunit at WCLC 2026.
Humanity Health and Quest Diagnostics have launched a biological age analysis add-on for select health profile tests in the US, allowing users to assess aging biomarkers using routine blood samples.
Hematogenix’s next-generation flow cytometry assay was used as the pivotal efficacy measure supporting FDA accelerated approval of ZENBEXUS, the first CELMoD therapy for multiple myeloma.
Precision BioLogic reports rising demand for its chromogenic factor VIII assay as labs prepare for new hemophilia A therapies, including bispecific antibodies submitted for FDA review by Novo Nordisk.
Health Canada has approved Fujirebio’s Lumipulse G NfL Blood and pTau 217 Plasma assays, expanding access to blood-based neurology biomarkers for clinical use on the Lumipulse G immunoassay platform.
Pillar Biosciences and Hamilton Company have launched an automated NGS library prep method for the oncoReveal Nexus 21 Gene Panel, validated for use on Hamilton’s Microlab STAR and STARlet liquid handling systems.
Astorg has completed its acquisition of Thermo Fisher’s global microbiology business, establishing an independent diagnostics company. Dirk Bontridder has been named CEO.
Invivoscribe has begun shipping its PrepQuant System in North America, an automated platform designed to streamline nucleic acid extraction, concentration, and quantification for MRD testing workflows.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
The automated urinalysis system integrates chemistry and microscopy to help labs manage higher testing volumes and reduce manual reviews to under 3%, according to the company.